Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a multicenter center, 2-arms prospective randomized phase II trial which evaluates whether tocilizumab with gemcitabine/nab-paclitaxel is more effective than gemcitabine/nab-paclitaxel.
Epistemonikos ID: 525c47d1f2cacc0becae71c87db8640f0a199ecc
First added on: May 13, 2024